GUS D HALAS Insider Trading $OPRX OptimizeRx Corp
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GUS D HALAS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GUS D HALAS. GUS D HALAS is Director in HOOPER HOLMES INC ($HH) and President & CEO in T-3 ENERGY SERVICES INC ($TTES) and Director in SCHOOL SPECIALTY INC ($SCOO) and Director in Triangle Petroleum Corp ($TPLM) and Director in OptimizeRx Corp ($OPRX).
GUS D HALAS in OptimizeRx Corp
Trading Symbol: OPRXIndustry: SERVICES-BUSINESS SERVICES, NEC [7389]
Position of GUS D HALAS: Director
Holdings: 64,421 shares
Current Value: $47,672
Latest Transaction: Apr 02 2021
$OPRX Market Capitalization: $22.85M
$OPRX Previous Close: $0.74
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of GUS D HALAS in OptimizeRx Corp
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, HH, OPRX, SCOO, TTES, TPLM
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 02 2021 | OPRX | OptimizeRx Corp | HALAS GUS D | Director | Grant | A | 0.00 | 539 | 0 | 64,421 | 63.9 K to 64.4 K (+0.84 %) |
Jul 02 2020 | OPRX | OptimizeRx Corp | HALAS GUS D | Director | Grant | A | 0.00 | 1,937 | 0 | 61,897 | 60 K to 61.9 K (+3.23 %) |
Mar 31 2020 | OPRX | OptimizeRx Corp | HALAS GUS D | Director | Grant | A | 0.00 | 2,784 | 0 | 59,960 | 57.2 K to 60 K (+4.87 %) |
Jan 07 2020 | OPRX | OptimizeRx Corp | HALAS GUS D | Director | Grant | A | 0.00 | 2,084 | 0 | 57,176 | 55.1 K to 57.2 K (+3.78 %) |
Nov 13 2019 | OPRX | OptimizeRx Corp | HALAS GUS D | Director | Buy | P | 9.80 | 5,000 | 49,000 | 55,092 | 50.1 K to 55.1 K (+9.98 %) |
Oct 02 2019 | OPRX | OptimizeRx Corp | HALAS GUS D | Director | Grant | A | 0.00 | 2,084 | 0 | 50,092 | 48 K to 50.1 K (+4.34 %) |
Mar 29 2019 | OPRX | OptimizeRx Corp | HALAS GUS D | Director | Grant | A | 0.00 | 2,084 | 0 | 48,008 | 45.9 K to 48 K (+4.54 %) |
Nov 20 2018 | OPRX | OptimizeRx Corp | HALAS GUS D | Director | Grant | A | 14.30 | 3,000 | 42,900 | 45,924 | 42.9 K to 45.9 K (+6.99 %) |
Oct 10 2018 | OPRX | OptimizeRx Corp | HALAS GUS D | Director | Grant | A | 0.00 | 2,084 | 0 | 42,924 | 40.8 K to 42.9 K (+5.10 %) |
Jul 03 2018 | OPRX | OptimizeRx Corp | HALAS GUS D | Director | Grant | A | 0.00 | 2,084 | 0 | 40,840 | 38.8 K to 40.8 K (+5.38 %) |
Jan 12 2018 | OPRX | OptimizeRx Corp | HALAS GUS D | Director | Grant | A | 0.00 | 6,250 | 0 | 116,269 | 110 K to 116.3 K (+5.68 %) |
Oct 02 2017 | OPRX | OptimizeRx Corp | HALAS GUS D | Director | Grant | A | 0.00 | 6,250 | 0 | 110,019 | 103.8 K to 110 K (+6.02 %) |
Jun 30 2017 | OPRX | OptimizeRx Corp | HALAS GUS D | Director | Grant | A | 0.00 | 6,250 | 0 | 103,769 | 97.5 K to 103.8 K (+6.41 %) |
Apr 04 2017 | OPRX | OptimizeRx Corp | HALAS GUS D | Director | Grant | A | 0.00 | 6,250 | 0 | 97,519 | 91.3 K to 97.5 K (+6.85 %) |
Mar 21 2017 | OPRX | OptimizeRx Corp | HALAS GUS D | Director | Buy | P | 0.77 | 16,990 | 13,082 | 91,269 | 74.3 K to 91.3 K (+22.87 %) |
Mar 21 2017 | OPRX | OptimizeRx Corp | HALAS GUS D | Director | Buy | P | 0.77 | 5,000 | 3,850 | 74,279 | 69.3 K to 74.3 K (+7.22 %) |
Mar 15 2017 | OPRX | OptimizeRx Corp | HALAS GUS D | Director | Buy | P | 0.74 | 8,010 | 5,927 | 69,279 | 61.3 K to 69.3 K (+13.07 %) |
Jan 04 2017 | OPRX | OptimizeRx Corp | HALAS GUS D | Director | Grant | A | 0.00 | 6,250 | 0 | 61,269 | 55 K to 61.3 K (+11.36 %) |
Jul 15 2016 | OPRX | OptimizeRx Corp | HALAS GUS D | Director | Grant | A | 0.00 | 6,250 | 0 | 55,019 | 48.8 K to 55 K (+12.82 %) |
Oct 07 2015 | OPRX | OptimizeRx Corp | HALAS GUS D | Director | Buy | P | 1.26 | 10,000 | 12,600 | 48,769 | 38.8 K to 48.8 K (+25.79 %) |
Sep 30 2015 | OPRX | OptimizeRx Corp | HALAS GUS D | Director | Grant | A | 0.00 | 6,250 | 0 | 38,769 | 32.5 K to 38.8 K (+19.22 %) |
Jul 02 2015 | OPRX | OptimizeRx Corp | HALAS GUS D | Director | Grant | A | 0.00 | 6,250 | 0 | 32,519 | 26.3 K to 32.5 K (+23.79 %) |
Apr 29 2015 | OPRX | OptimizeRx Corp | HALAS GUS D | Director | Grant | A | 1.15 | 6,250 | 7,188 | 26,269 | 20 K to 26.3 K (+31.22 %) |
Page: 1